SCHEMBL232032

SCHEMBL232032

CC(C)SC(=N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL7532633 0.97
Hydrochloric Acid SCHEMBL31317509 0.97
Iodide SCHEMBL31317516 0.97
SCHEMBL2788607 0.87 NOS3 (0.75)
SCHEMBL2787759 0.79 NOS3 (0.62)
Phosphoric Acid Monomethyl Ester SCHEMBL8136601 0.79 NOS3 (0.62)
SCHEMBL1063077 0.78
SCHEMBL8150625 0.78 NOS3 (0.60)
SCHEMBL11191940 0.78
Bromide SCHEMBL5667040 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 318 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8183409-B2 High yield and rapid synthesis methods for producing metallo-organic salts OSTEOLOGIX A/S (DK) 2012-05-22 US claimed
US-20090291926-A1 HIGH YIELD AND RAPID SYNTHESIS METHODS FOR PRODUCING METALLO-ORGANIC SALTS CHRISTGAU STEPHAN 2009-11-26 US claimed
EP-1633311-A4 COMPOSITIONS AND METHODS FOR MODULATING S-NITROSOGLUTATHIONE REDUCTASE UNIV DUKE (US) 2009-06-03 EP claimed
US-20080317849-A1 Method for Improving the Medical Treatment of Pain OSTEOLOGIX A/S (DK) 2008-12-25 US claimed
US-20070282127-A1 High Yield And Rapid Synthesis Methods For Producing Metallo-Organic Salts OSTEOLOGIX A/S 2007-12-06 US claimed
EP-1744770-A2 HIGH YIELD AND RAPID SYNTHESES METHODS FOR PRODUCING METALLO-ORGANIC SALTS Osteologix A/S (DK) 2007-01-24 EP claimed
EP-1633311-A2 COMPOSITIONS AND METHODS FOR MODULATING S-NITROSOGLUTATHIONE REDUCTASE DUKE UNIVERSITY (US) 2006-03-15 EP claimed
WO-2005108339-A2 HIGH YIELD AND RAPID SYNTHESES METHODS FOR PRODUCING METALLO-ORGANIC SALTS OSTEOLOGIX A/S (DK) 2005-11-17 WO claimed
US-20050014697-A1 Compositions and methods for modulating S-nitrosoglutathione reductase DUKE UNIVERSITY 2005-01-20 US claimed
WO-2005000229-A2 COMPOSITIONS AND METHODS FOR MODULATING S-NITROSOGLUTATHIONE REDUCTASE DUKE UNIVERSITY (US) 2005-01-06 WO claimed
US-20020156129-A1 Method of treating pruritus and a pharmaceutical composition for the method IKEDA MOHANDO CO., LTD. (JP) 2002-10-24 US claimed
EP-0928191-B1 PHARMACEUTICAL COMPOSITIONS COMPRISING S-ALKYLISOTHIOURONIUM DERIVATIVES MEDITOR PHARMACEUTICALS LTD (IL) 2002-08-28 EP claimed
EP-0670720-A1 ENZYME INHIBITORS THE WELLCOME FOUNDATION LIMITED (GB) 1995-09-13 EP claimed
WO-1994012165-A2 ENZYME INHIBITORS THE WELLCOME FOUNDATION LIMITED (GB) 1994-06-09 WO claimed
US-20250205232-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-06-26 US disclosed
US-12209094-B2 CCR2 receptor antagonists and uses thereof CENTREXION THERAPEUTICS CORPORATION (US) 2025-01-28 US disclosed
US-12168009-B2 Modulators of cystic fibrosis transmembrane conductance regulator VERTEX PHARMACEUTICALS INCORPORATED (US) 2024-12-17 US disclosed
US-20020156129-A1 Method of treating pruritus and a pharmaceutical composition for the method IKEDA MOHANDO CO., LTD. (JP) 2002-10-24 US disclosed
EP-0670720-A1 ENZYME INHIBITORS THE WELLCOME FOUNDATION LIMITED (GB) 1995-09-13 EP disclosed
WO-1994012165-A2 ENZYME INHIBITORS THE WELLCOME FOUNDATION LIMITED (GB) 1994-06-09 WO disclosed